Story · Medicine & Biotech · Public Health

Epidemiologist who studies 'eye stroke' in Ozempic patients explains the new FDA warning… and whether you should be concerned

1 outlet · first reported by Daily Mail Health on

GLP-1 drugs must now carry a warning label about a potential link to a rare eye condition that can result in vision loss, the Food and Drug Administration (FDA) announced this week. (Daily Mail Health)

Coverage, in order

  1. Daily Mail Health UK mainstream study
    Epidemiologist who studies 'eye stroke' in Ozempic patients explains the new FDA warning… and whether you should be concerned

    GLP-1 drugs must now carry a warning label about a potential link to a rare eye condition that can result in vision loss, the Food and Drug Administration (FDA) announced this week.

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.